Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasisSatoshi Takagi, Ryohei Katayama, Yosuke Seto et al.|Oncogene|2021Cited by 48
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcomaSatoshi Takagi, Ryohei Katayama, Mikako Nakajima et al.|Oncogene|2024Cited by 4